Allergic reactions to the new mRNA-based COVID-19 vaccines are rare, typically mild and treatable, and they should not deter people from becoming vaccinated, according to research from the Stanford University...

By NewsDesk  @infectiousdiseasenews Researchers from the University of Oxford have today reported on findings on the vaccinated people who are at greatest risk from severe Covid-19 leading to hospitalization...

By Teddy Cambosa Following Vietnam president Nguyen Xuan Phuc’s departure for a presidential visit to Cuba, the country has approved the use of the Abdala vaccine, developed by Cuba’s Center for Genetic...

COVID-19 vaccines are effective at preventing hospitalizations and emergency department visits caused by the Delta variant, according to data from a national study. That data also indicate that Moderna’s...

NewsDesk  @infectiousdiseasenews In February of this year, the Royal Government of Cambodia launched its national vaccination campaign against COVID-19. The stated goal at the time was to vaccinate...

NewsDesk  @infectiousdiseasenews The Argentina Ministry of Health reported today 38.1 percent of the country’s population completed their vaccination schedule against the COVID-19 disease. Officials...

NewsDesk  @infectiousdiseasenews The UK Health Security Agency announced that as of September 1, the Shingrix vaccine will be available for people who are 70 to 79 years of age with weakened immune systems...

NewsDesk  @infectiousdiseasenews The Ministry of Health’s vaccination campaign against COVID-19 continues at an accelerated pace. On September 2, Brazil registered another important mark to put...

NewsDesk  @infectiousdiseasenews The Norwegian Institute of Public Health, aka Folkehelseinstituttet reported 92 percent (251,000) of employees in schools and kindergartens through September 2 received...

NewsDesk @bactiman63 The Portugal Direção-Geral da Saúde reported today the Vaccination Report No. 28 indicates that about 80% of the population has at least one dose of vaccine COVID-19 and 72%...